Assoc. Prof. Kate Gartlan is an immunologist with a strong interest in inflammatory diseases and in vivo modelling to investigate inflammation and cellular immunity. She has trained in a range of world-class research environments in Australia and abroad, including the University of Oxford (UK), the Fred Hutch CRC (Seattle, USA), WEHI, Burnet Institute, Monash University and QIMR Berghofer. In 2019, she established the Immunopathology Laboratory at QIMRB, where her research is focussed on inflammation and adaptive immune polarisation in disease settings such as graft-versus-host disease (GVHD), cancer, autoimmunity and infection. Her work in this area involves academic, clinical and industry collaborations to investigate novel approaches to modulating inflammatory responses. A/Prof Gartlan currently holds an MRFF funded fellowship through the REDI initiative (Research Exchange and Development within Industry) in collaboration with CSL Ltd.